专栏名称: 药明康德
全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台,帮助任何人、任何公司更快、更好地研发新医药产品,探索无限可能
目录
相关文章推荐
51好读  ›  专栏  ›  药明康德

WuXi AppTec Released 2024 ESG Report

药明康德  · 公众号  · 药品  · 2025-04-03 17:46

正文

请到「今天看啥」查看全文


▎WuXi AppTec

WuXi AppTec released its 2024 Environmental, Social and Governance (ESG) Report today.


In 2024, our progress has been recognized by major global ESG rating agencies, including MSCI, EcoVadis, CDP, S&P Global, Morningstar Sustainalytics, FTSE, and ISS. These honors further inspire our commitment to embedding ESG practices in our culture, strategic planning, and daily operations.


Learn more about our ESG performance through the infographic below.


版权说明:本文来自药明康德内容团队,欢迎个人转发至朋友圈,谢绝媒体或机构未经授权以任何形式转载至其他平台。转载授权请在「药明康德」微信公众号回复“转载”,获取转载须知。


分享 在看 ,聚焦全球生物医药健康创新









请到「今天看啥」查看全文